The Cell and Gene Therapy Conclave is designed as a platform to gain valuable insights into the most innovative developments in CGT. The two day Conclave will take a deep dive into themes of therapy bioprocessing and cell line development strategies, as well as the latest therapeutic developments & manufacturing technologies in cell and gene based therapy. The Conclave unites over 150 senior attendees from leading pharmaceutical organisations, biopharma, biotech companies and internationally renowned academic institutes, alongside 15+ leading solution providers, to provide a focused forum for thought-provoking discussions. Over 30+ scientific presentations over 2 days ensure a deep focus on the latest advancements in CGT based therapies, from 3D Cell Culture, bioprocessing and manufacturing; to stem cell regenerative medicine research as well as bio banking.